Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of cost gouging, declaring the stark distinction concerning U.S. selling prices and those in Europe and copyright.California biotech behemoth Amgen ditched designs for an experimental weight loss tablet in M